We compared 30-day case-fatality rates for patients infected with Clostridium difficile possessing genes for toxins A and B without binary toxin (n = 212) with rates for patients infected with C. difficile possessing genes for A, B, and binary toxin. The latter group comprised patients infected with strains of PCR ribotype 027 (CD027, n = 193) or non-027 (CD non-027, n = 72). Patients with binary toxin had higher case-fatality rates than patients without binary toxin, in univariate analysis (relative risk [RR] 1.8, 95% confidence interval [CI] 1.2-2.7) and multivariate analysis after adjustment for age, sex, and geographic region (RR 1.6, 95% CI 1.0-2.4). Similar case-fatality rates (27.8%, 28.0%) were observed for patients infected with CD027 or CD non-027. Binary toxin either is a marker for more virulent C. difficile strains or contributes directly to strain virulence. Efforts to control C. difficile infection should target all virulent strains irrespective of PCR ribotype.
relapses (8, 9, 11, 12) . However, whether it really causes increased severity is questionable.
Characteristics observed by previous studies may be due to selection bias or to the procedures used for diagnostic testing and reporting of cases; disease severity was similar in 2 groups of patients (PCR ribotype 027 and non-027) when recruitment to the study was done without reference to clinical signs and symptoms or PCR ribotype (13) .
The pathogenicity of C. difficile is based on the action of at least 1 of the 2 main cytotoxins (A and B) acting as glycosyltransferases that modify guanose triphosphatases within the intestinal epithelial cells and lead to the disruption of the actin cytoskeleton. A recent study, which used a gene knock-out system, reinforced the fact that toxins A and B are comparable in terms of virulence, as shown by in vitro cytotoxicity and virulence in vivo (14) . A binary toxin C. difficile transferase is found in some strains and belongs to the actin-modifying adenide dinucleotide protein-ribosyltransferases, which also impair the structure of actin cytoskeleton in epithelial cells (15, 16) . The pathologic significance of binary toxin is not yet clear. However, a recent study reports that binary toxin not only affects the actin cytoskeleton but also induces the formation of microtubule-based protrusions on the surface of epithelial cells, leading to increased adherence (17) .
Cultures positive for C. difficile are notifiable by the diagnostic laboratories in Denmark as part of the surveillance for gastrointestinal infections; in addition, isolates are selected under certain criteria and submitted to the National Reference Laboratory at Statens Serum Institut for further typing. The aim of the present study was to determine the case-fatality rate after diagnosis with C. difficile, according to toxin profile and PCR ribotype. difficile PCR ribotype 027 were found for the first time in Denmark (7). They were reinforced in 2009, when the country experienced the first large C. difficile PCR ribotype 027 outbreak, which involved different hospitals of the Copenhagen Capital Region (18) . Information on which specific criteria were used for submission of the individual isolates for subtyping was not available. No laboratory standard for primary diagnostics of CDI has been developed at the national level, and clinical microbiology departments use different methods, including environmental impact assessment, culture, PCR, or standard cytotoxin assays.
All isolates referred to Statens Serum Institut are genotyped to detect genes for the 3 toxins (A and B, and binary toxin). PCR ribotyping is subsequently performed on isolates possessing the genes for all 3 toxins (Figure 1 ). The methods used for genotyping of toxins and PCR ribotyping have been described in detail elsewhere (19, 20) . This study was approved by the Danish Data Protection Board.
Definitions
Patients were assigned to 4 groups, depending on the characteristics of the isolates (Figure 1 ). Infected patients with an isolate possessing genes for toxins A and B and binary toxin were categorized either as C. difficile PCR ribotype 027 (CD027) or C. difficile PCR ribotype non-027 (CD non-027). A third group included patients infected with a strain possessing genes encoding for toxins A and toxin B, but not the binary toxin genes (CD A and B). A fourth group was created by subtracting the other 3 groups from patients with C. difficile infection that were notified to the surveillance laboratory system. Therefore, such patients were infected with isolates not referred for typing, presumably because the criteria for submission were not fulfilled.
We refer to this group as unselected C. difficile unselected (CD-unselected).The distribution of the different PCR ribotypes in the group CD non-027 was described.
Only the first episode of infection of the patient was considered. The first episode of CD027 overruled the first episode of CD non-027; the first episode of CD non-027 overruled the first episode of CD A and B; and the first episode of CD A and B overruled the first episode of unselected C. difficile infection. Therefore, the final dataset included only 1 observation per patient. The date on which the stool sample was collected was defined as the date of diagnosis.
Statistical Methods
Kaplan Meier survival curves were created to determine the effect of time after diagnosis on the risk for death. Differences between curves were compared by using the log-rank test.
Multivariate Poisson regression was used to estimate the risk ratio of death within 30 days after diagnosis. For survival analysis, patients were categorized into 2 groups, according to the presence or absence of binary toxin. Analysis was performed with STATA version 10 (StataCorp, College Station, TX, USA). Case-patients for whom 30 days of follow-up after infection could not be completed were excluded from the analysis (163 cases).
Results
After the 2 microbiological datasets were merged, 2,299 case-patients with a first episode of infection were identified for the 17-month study. Of the 2,299 case-patients, isolates from 477 were referred to the national laboratory and were genotyped for toxins; of these 265 had genes for toxin A, toxin B, and binary toxin and were further ribotyped by PCR. Therefore, the 4 groups of patients with C. difficile infection used for the study consisted of 1,822 CD unselected, Gender was equally distributed among the 4 groups of patients with CD unselected, CD 027, CD non-027, and CD A and B. The proportion of case-patients <50 years of age was much higher in the group with CD unselected (27.1%), compared with that of groups CD027 (4.6%) and CD non-027 (9.7%), which had more case-patients >80 years of age ( Table 1) Table 1 ).
The case-fatality rate in patients 30 days after diagnosis (28%) was independent of PCR ribotype in patients infected with strains that were positive for the binary toxin. More On the basis of these observations, which showed a similar case-fatality pattern for the groups that possessed the genes for the binary toxin, in the regression analysis, we combined these 2 groups with the genes for the binary toxin (CD027 and CD non-027) into 1 group, and compared it with the group not possessing the binary toxin (CD A and B) . Therefore, in the regression analysis, the group of CD unselected isolates was excluded because these isolates were not submitted for characterization.
Univariate analysis showed that the relative risk (RR) for death within 30 days after diagnosis was (RR 1.8, 95% CI 1.2-2.7) for case-patients infected with C. difficile that possesses the genes for binary toxin in addition to toxin A and B, as compared with those infected with strains possessing only genes for toxin A and B, which provided the reference level (Table 2) .
Multivariate analysis, after adjustment for age, sex, and region, showed that the relative risk became 1.6 (95% CI 1.0-2.4) for case-patients infected with the strains encoding the genes for the binary toxin when compared with the reference group of patients infected with strains without the genes for binary toxin ( Table 2) .
Discussion
We used surveillance data to describe the case-fatality rate after a diagnosis of C. difficile infection. We found that the case-fatality rate is highest after infection with strains that possess genes for the binary toxin in addition to toxins A and B, irrespective of the PCR ribotype. Strains encoding genes for toxins A and B, but not binary toxin, showed a lower case-fatality risk.
A number of studies have addressed the issue of risk for death and severity of disease after infection with C. difficile. Overall, C. difficile PCR ribotype 027 has been associated with more severe disease and increased death rates. Nevertheless, many studies did not have a strict sampling frame or appropriate epidemiologic design, and their findings have been questioned by recent evidence (13, 21) . Our results are consistent with the initial findings that C. difficile PCR ribotype 027 is associated with elevated risk of death, but we elaborate further on the molecular characterization according to toxin profile. We suggest that the previously observed high casefatality rate observed in C. difficile infection cannot be solely ascribed to excess risk for death after infection with PCR ribotype 027; other markers of virulence may be more appropriate than the PCR ribotype itself. The inclusion of case-patients on the basis of clinical findings only (1, 8, 9, 12) , the different criteria used to select strains for PCR ribotyping (13, (21) (22) (23) , or the lack of differentiation in separate groups according to toxin profiles (24) might have accounted for variation of estimates across the studies, as well as an overestimation of the risk for death associated with C. difficile PCR ribotype 027.
We observed a 28% case-fatality rate at 30 days for the 2 groups possessing the binary toxin: estimates from previous studies in Canada indicated a risk for death of 23% for patients with C. difficile-associated disease (CDAD), in a hospital in which C. difficile PCR ribotype 027 strain made up two-thirds of the isolates (12); or of 25% in another study involving 12 hospitals in which case-patients with CDAD were compared with controls without CDAD. In the latter study, 129/157 strains examined had pulsed-field gel electrophoresis patterns identical to NAP1 (8) . In the Netherlands, 12.9% lethality was reported for C. difficile PCR ribotype 027 as compared with 7.0% in other C. difficile PCR ribotypes non-027 (21). (26) . Binary toxin-positive strains that produced neither toxins A and B were investigated in the rabbit ileal loop model to elucidate the contribution of binary toxin in the pathogenesis of CDI (27) . This study showed that binary toxin contributed to marked nonhemorrhagic fluid responses when responses of nontoxigenic strains were compared.
However, strains that produced toxins A and B gave rise to hemorrhagic fluid responses in this assay. In the same study, challenge with clindamycin-treated hamsters resulted in colonization of the binary toxin-positive strains but not diarrhea and death as seen for the strains that produced toxins A and B. Therefore, binary toxin may play an adjunctive role in the pathogenesis of disease caused by strains positive for toxins A and B (27) .
Historically, C. difficile infection was not considered a severe disease, and studies performed 15 years ago reported case fatality rates of 3.0%-3.5% (28, 29) . Due to the current laboratory surveillance system, we were able to quantify 30-day case-fatality rate of a reference group (CD unselected isolates not referred for typing) at 14%, which provides an updated estimate of such baseline category. In a registry-based study in Finland, performed before C. difficile PCR ribotype 027 was identified in the country for the first time, a 14.2% 30-day death rate was reported among those discharged with a CDAD-related diagnosis (30) . In Quebec, 13.8% of deaths reported 30 days after CDAD diagnosis were observed at the beginning of the C. difficile PCR ribotype 027 epidemic in 2003 (9) .
Many studies have reported that a consistent fraction of the deaths occurring after C. difficile infection will be attributable to the bacterium (1, 8, 12, (21) (22) (23) 31) and that attributable death increases linearly with age (8, 31) . In our study, we could not differentiate between death after infection and attributable death because the registries did not contain information on the cause of death nor underlying illness. An excess proportion of deaths caused by CD027 and other strains with binary toxin corroborates recent evidence from Canada, which showed an increased risk for death in patients infected with the NAP1 strain (24) Due to the availability of the national registries, we were able to investigate the casefatality rate for a large cohort of patients and to get statistically significant results when investigating groups with different toxin profiles of the same infection. In addition, we performed multivariate analysis adjusting for age, sex, and region. Multivariate analysis indicated that the risk of death was increased by 60% (RR 1.6) for the strains possessing the binary toxin, irrespective of age, sex, and region of the laboratory submitting the isolates. Use of the registries made it possible to design the study on an individual patient basis, not only on isolates, and made it unlikely that deaths were missed.
The main limitations of the study were that we were not able to collect data on underlying illness from the registries and that the toxin gene profile of the unselected isolates not referred for further typing was not characterized. We accounted for the latter possible bias by excluding this group in the regression analysis, and by using the group toxin profiled without genes for binary toxin (CD A and B) as the reference level. The lack of availability of data on underlying illness means that the long-term case fatality explored with the Kaplan Meier survival function must be interpreted with caution. However, our estimates at 3 months after infection were comparable to those of a previous study in which confounding caused by underlying illness was addressed (12) . Therefore, C. difficile could play a role in risk for death in the longer term. An increase in long-term deaths after bacterial gastrointestinal infections has been observed (32, 33) .
Complications of operations performed after toxic megacolon, disruption of the colonic flora and intestinal cells, subsequent malabsorbtion, and, most importantly, the recurrence of infection, could be some of the mechanisms involved in long-term deaths after infection with C. difficile.
About 19%-20% of first episodes of infection with C. difficile will be followed by a recurrence (34) , either due to a relapse or reinfection with another strain.
In conclusion, our registry-based study demonstrates that patients infected with C. difficile strains possessing the binary toxin genes and genes encoding toxins A and B have a higher 30-day case-fatality rate, irrespective of PCR ribotype, when compared with strains that have toxins A and B only. Early recognition of the toxin profile might be beneficial in terms of clinical management of the disease. Future studies should address whether the binary toxin or an unknown co-expressed factor might be responsible for increased case-fatality rates. C. difficile PCR ribotype 027 can no longer be considered the only PCR ribotype associated with severe disease, and efforts to control CDI should target all virulent strains of C. difficile, not only C. difficile PCR ribotype 027. 
